Feature | TCT | September 14, 2018| Dave Fornell, Editor

What You Need to Know to Prepare for TCT 2018

Videos, news and articles regarding the hottest topics and data presentations at the upcoming 2018 Transcatheter Cardiovascular Therapeutics annual meeting

Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics. #TCT #TCT18 #TCT2018

The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional cardiology conference can be overwhelming. So, to prepare for the meeting, here is a list of some key items that will be covered in sessions, live cases and late-breaking trial presentations. It includes videos, articles, news and U.S. Food and Drug Administration (FDA) clearances that will be among the hottest topics at this year’s TCT, in San Diego., Sept. 21-25, 2018. Access the TCT 2018 webite for the agenda and more information at www.crf.org/tct.

 

TCT Announces Late-breaking Cardiovascular Clinical Trials

Key Interventional Technology Trends at TCT 2017

VIDEO: The Current State of Bioresorbable Stents in 2018— an interview with Patrick Serruys, M.D.

VIDEO: Tricuspid Device Clinical Trial Overview — an interview with Ori Ben-Yehuda, M.D.

Latest Data on Cardiac Technology From ACC.18

VIDEO: Tricuspid Valve Imaging and Interventions Developing Hand-in-hand — an interview with Rebecca Hahn, M.D.

 

VIDEO: Will CT-FFR Replace Diagnostic Angiograms? — an interview with Patrick Serruys, M.D.

FFR-CT is Ready for Prime-time Evaluation of Coronary Disease

VIDEO: The Essentials of CT Transcatheter Valve Imaging — an interview with Jonathon Leipsic, M.D.

SCAI 2018 Late-breaking Clinical Trials

VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast — an interview with Roxana Mehran, M.D.

VIDEO: Detection of Vulnerable Plaque and Pre-emptive Stenting — an interview with Ron Waksman, M.D.

 

EuroPCR 2018 Late-breaking Trials in Interventional Cardiology

VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch — an interview with Juan Granada, M.D.

Length of Stay Impacts TAVR Outcomes

VIDEO: Clinical Outcomes With the Lotus TAVR Valve — an interview with Ted Feldman, M.D.

VIDEO: Editor's Choice of the Most Innovative New Technologies at TCT 2017

Improving Cath Lab Efficiency With New Hemodynamic Systems

 

VIDEO: What Went Wrong With the Absorb Stent? — an interview with Ajay Kirtane, M.D.

New Technology Directions in Fractional Flow Reserve (FFR)

VIDEO: Transcatheter Mitral Valve Implantation in Practice and Technologies in Development — an interview with Adam Greenbaum, M.D.

Advances in Transcatheter Tricuspid Valve Technologies

VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis — an interview with Philippe Genereux, M.D.

VIDEO: History of Radial Artery Access — an interview with Ferdinand Kiemeneij, M.D.

 

VIDEO: Applications in Cardiology for 3-D Printing and Computer Aided Design — an interview with Dee Dee Wang, M.D.

How to Tackle Coronary CTOs

VIDEO: Angiography Image-based FFR May Eliminate Need for Pressure Wires — an interview with William Fearon, M.D. 

Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions

VIDEO: iFR Found More Cost Effective Over Standard FFR — an interview with Manesh Patel, M.D.

VIDEO: New Technology to Treat Chronic Total Occlusions (CTOs), an interview with Farouc Jaffer, M.D., Ph.D.

 

VIDEO: Treating Chronic Total Occlusions, an interview with Bill Lombardi, M.D.

Defining the Cath Lab Workplace Radiation Safety Hazard

VIDEO: How to Avoid Acute Kidney Injury in the Cath Lab — an interview with Hitinder Gurm, M.D.

VIDEO: Editor's Choice of the Most Innovative New Technology at ACC 2018

FDA Clears First Reversal Agent for Rivaroxaban, Apixaban Anticoagulants

 

How to Perform Transcaval TAVR Access

VIDEO: New Data on LAA Occlusion From the PREVAIL and PROTECT Trials — an interview with Vivek Reddy, M.D.

FDA Clears Implantable Heart Attack Warning Device

VIDEO: Overview of the National Cardiogenic Shock Initiative — an interview with William O'Neill, M.D.

Renal Denervation Shows Significant Drop in Hypertension

10 Reasons Why it is Time to Learn More About Cardiogenic Shock — by Emmanouil Brilakis, M.D., and Srihari Naidu

 

Recently Introduced Angiography Imaging Technology

VIDEO: Outcomes Following Urgent TAVR - Results from the TVT Registry — an interview with Sammy Elmariah, M.D.

Advances and Trends in Vascular Closure Devices

Cardiac Fusion Imaging Provides Benefits for Transcatheter Guidance in Structural Heart Interventions

VIDEO: The Role and Responsibilities of the Cath Lab Manager — an interview with Bernadette Speiser, BSN, RCIS

Abbott Begins Tendyne Transcatheter Mitral Valve U.S. Pivotal Trial

 

VIDEO: TAVR for Degenerated Surgical Valves — Valve-in-Valve TAVR Procedures — an interview with Sammy Elmariah, M.D.

Dose-Lowering Practices for Cath Lab Angiography

PCI Procedure Volume Recovers With New Focus on Complex PCI in the U.S. Interventional Cardiology Market

VIDEO: Addressing Adult Congenital Heart Referrals — an interview with Ami Bhatt, M.D.

VIDEO: How Consolidation Into Larger Health Systems Can Improve Access to TAVR

VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke — an interview with John Rhodes, M.D.

 

VIDEO: New Frontiers in Radial Access — an interview with Mladen I. Vidovich, M.D.

Understanding the Design and Function of Guidewire Technology

VIDEO: Basics of Interventional Guidewire Design and Function, an interview with Dimitri Karmpaliotis, M.D., Ph.D., FACC

What Trends are Ahead in Cardiovascular Medicine in 2018?
 

Related Content

Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020

Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip was the subject of two studies, including use to aid heart transplant patients. Bottom right, the Boston Scientific Acurate neo TAVR valve performed below the Sapien 3 and CoreValve Evolut.

Feature | TCT | October 29, 2020 | Dave Fornell, Editor
Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials prese
TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT
Feature | TCT | October 29, 2020
October 29, 2020 — The late-breaking studies are one of the hallmarks of the annual...
Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 

News | TCT | October 14, 2020
October 14, 2020 — The American College of Cardiology (ACC) and the...
Videos | TCT | August 01, 2020
With COVID-19 forcing all medical conferences to go virtual in 2020,...
EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment for structural heart procedures. #TCT2019 #TCT #TCT19

EchoPixel showed technology at TCT 2019 that creates live holograms in the cath lab from 3-D TEE imaging. It projects the holograms on a special display screen that does not require the user to wear 3-D glasses. The interventional cardiologist can use hand movements and a foot switch to move the image around without breaking the sterile field. It offers a new way to visualize catheters, device positioning and deployment in structural heart procedures. (Photos by Dave Fornell)

Feature | TCT | November 04, 2019 | Dave Fornell, Editor
The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual ...
TCT 2019 Late-breaking Presentations in the main arena. The top interventional cardiology studies of 2019. #TCT #TCT19 #TCT2019
Feature | TCT | October 11, 2019
The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 late-breaking science...
Videos | TCT | October 03, 2018
DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the ex
cardiologist Ted Feldman, M.D., at TCT 2017. #TCT2018 #TCT #TCT18 TCT Late breaking trials, studies.
Feature | TCT | September 21, 2018
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking clini
Videos | TCT | November 15, 2017
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiova